
Rupal Dharia
Supervisory Patent Examiner (ID: 11240, Phone: (571)272-3880 , Office: P/2400 )
| Most Active Art Unit | 2181 |
| Art Unit(s) | 2305, 2456, 2441, 2100, 2400, 2443, 2181, 2492, 2189, 2781, 2141 |
| Total Applications | 411 |
| Issued Applications | 349 |
| Pending Applications | 24 |
| Abandoned Applications | 39 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
| 08/644781 | ASPB28 INSULIN CRYSTALS | May 9, 1996 | Abandoned |
Array
(
[id] => 3688781
[patent_doc_number] => 05696152
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-09
[patent_title] => 'Taxol composition for use as organ preservation and cardioplegic agents'
[patent_app_type] => 1
[patent_app_number] => 8/646055
[patent_app_country] => US
[patent_app_date] => 1996-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4467
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/696/05696152.pdf
[firstpage_image] =>[orig_patent_app_number] => 646055
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/646055 | Taxol composition for use as organ preservation and cardioplegic agents | May 6, 1996 | Issued |
Array
(
[id] => 3695666
[patent_doc_number] => 05679775
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-21
[patent_title] => 'Process and device for the simultaneous extracorporeal elimination of tumour necrosis factor and bacterial lipopolysaccharides from whole blood and/or blood plasma'
[patent_app_type] => 1
[patent_app_number] => 8/634919
[patent_app_country] => US
[patent_app_date] => 1996-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3949
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/679/05679775.pdf
[firstpage_image] =>[orig_patent_app_number] => 634919
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/634919 | Process and device for the simultaneous extracorporeal elimination of tumour necrosis factor and bacterial lipopolysaccharides from whole blood and/or blood plasma | Apr 18, 1996 | Issued |
Array
(
[id] => 3826829
[patent_doc_number] => 05783557
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-21
[patent_title] => 'THF-.gamma.2 analogs and pharmaceutical compositions comprising them'
[patent_app_type] => 1
[patent_app_number] => 8/571985
[patent_app_country] => US
[patent_app_date] => 1996-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9113
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/783/05783557.pdf
[firstpage_image] =>[orig_patent_app_number] => 571985
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/571985 | THF-.gamma.2 analogs and pharmaceutical compositions comprising them | Mar 28, 1996 | Issued |
Array
(
[id] => 3832929
[patent_doc_number] => 05712252
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-01-27
[patent_title] => 'Method of augmenting soft tissue in mammals'
[patent_app_type] => 1
[patent_app_number] => 8/611613
[patent_app_country] => US
[patent_app_date] => 1996-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 5451
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/712/05712252.pdf
[firstpage_image] =>[orig_patent_app_number] => 611613
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/611613 | Method of augmenting soft tissue in mammals | Mar 7, 1996 | Issued |
Array
(
[id] => 3787018
[patent_doc_number] => 05736510
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-07
[patent_title] => 'Antibiotics 10381v, w, x,y, z1, z2, pre-b and t'
[patent_app_type] => 1
[patent_app_number] => 8/615209
[patent_app_country] => US
[patent_app_date] => 1996-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8975
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/736/05736510.pdf
[firstpage_image] =>[orig_patent_app_number] => 615209
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/615209 | Antibiotics 10381v, w, x,y, z1, z2, pre-b and t | Mar 6, 1996 | Issued |
Array
(
[id] => 3876412
[patent_doc_number] => 05747445
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-05
[patent_title] => 'Therapeutic preparation for inhalation'
[patent_app_type] => 1
[patent_app_number] => 8/583205
[patent_app_country] => US
[patent_app_date] => 1996-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 7207
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/747/05747445.pdf
[firstpage_image] =>[orig_patent_app_number] => 583205
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/583205 | Therapeutic preparation for inhalation | Jan 3, 1996 | Issued |
Array
(
[id] => 3735369
[patent_doc_number] => 05698516
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-16
[patent_title] => 'Biologically active vasopressin analogues'
[patent_app_type] => 1
[patent_app_number] => 8/553555
[patent_app_country] => US
[patent_app_date] => 1995-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1653
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/698/05698516.pdf
[firstpage_image] =>[orig_patent_app_number] => 553555
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/553555 | Biologically active vasopressin analogues | Dec 17, 1995 | Issued |
Array
(
[id] => 3927434
[patent_doc_number] => 05877154
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-02
[patent_title] => 'Pharmaceutical compositions for the treatment or prevention of disorders in the eye'
[patent_app_type] => 1
[patent_app_number] => 8/570813
[patent_app_country] => US
[patent_app_date] => 1995-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 5799
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/877/05877154.pdf
[firstpage_image] =>[orig_patent_app_number] => 570813
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/570813 | Pharmaceutical compositions for the treatment or prevention of disorders in the eye | Dec 11, 1995 | Issued |
Array
(
[id] => 3737932
[patent_doc_number] => 05698676
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-16
[patent_title] => 'Use of propylene oxide as an acid scavenger in peptide synthesis'
[patent_app_type] => 1
[patent_app_number] => 8/565465
[patent_app_country] => US
[patent_app_date] => 1995-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3263
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/698/05698676.pdf
[firstpage_image] =>[orig_patent_app_number] => 565465
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/565465 | Use of propylene oxide as an acid scavenger in peptide synthesis | Nov 29, 1995 | Issued |
Array
(
[id] => 3725020
[patent_doc_number] => 05672680
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-30
[patent_title] => 'Pentaclethera macroloba protein having insecticidal properties'
[patent_app_type] => 1
[patent_app_number] => 8/560727
[patent_app_country] => US
[patent_app_date] => 1995-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 6605
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/672/05672680.pdf
[firstpage_image] =>[orig_patent_app_number] => 560727
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/560727 | Pentaclethera macroloba protein having insecticidal properties | Nov 19, 1995 | Issued |
Array
(
[id] => 4040600
[patent_doc_number] => 05874227
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-23
[patent_title] => 'Cyclic CRF antagonists'
[patent_app_type] => 1
[patent_app_number] => 8/556578
[patent_app_country] => US
[patent_app_date] => 1995-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19649
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/874/05874227.pdf
[firstpage_image] =>[orig_patent_app_number] => 556578
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/556578 | Cyclic CRF antagonists | Nov 9, 1995 | Issued |
Array
(
[id] => 3810376
[patent_doc_number] => 05854387
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-29
[patent_title] => 'Simple method for the purification of a bioelastic polymer'
[patent_app_type] => 1
[patent_app_number] => 8/543020
[patent_app_country] => US
[patent_app_date] => 1995-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 10158
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/854/05854387.pdf
[firstpage_image] =>[orig_patent_app_number] => 543020
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/543020 | Simple method for the purification of a bioelastic polymer | Oct 12, 1995 | Issued |
Array
(
[id] => 3777056
[patent_doc_number] => 05817750
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-10-06
[patent_title] => 'Structural mimics of RGD-binding sites'
[patent_app_type] => 1
[patent_app_number] => 8/520535
[patent_app_country] => US
[patent_app_date] => 1995-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 10209
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/817/05817750.pdf
[firstpage_image] =>[orig_patent_app_number] => 520535
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/520535 | Structural mimics of RGD-binding sites | Aug 27, 1995 | Issued |
Array
(
[id] => 3737828
[patent_doc_number] => 05698670
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-16
[patent_title] => 'Aureobasidins'
[patent_app_type] => 1
[patent_app_number] => 8/505255
[patent_app_country] => US
[patent_app_date] => 1995-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18326
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 201
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/698/05698670.pdf
[firstpage_image] =>[orig_patent_app_number] => 505255
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/505255 | Aureobasidins | Aug 15, 1995 | Issued |
Array
(
[id] => 3833041
[patent_doc_number] => 05814599
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-29
[patent_title] => 'Transdermal delivery of encapsulated drugs'
[patent_app_type] => 1
[patent_app_number] => 8/511583
[patent_app_country] => US
[patent_app_date] => 1995-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 9
[patent_no_of_words] => 6771
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/814/05814599.pdf
[firstpage_image] =>[orig_patent_app_number] => 511583
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/511583 | Transdermal delivery of encapsulated drugs | Aug 3, 1995 | Issued |
Array
(
[id] => 3805463
[patent_doc_number] => 05830854
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-03
[patent_title] => 'Method of treating cystic fibrosis using a tachykinin receptor antagonist'
[patent_app_type] => 1
[patent_app_number] => 8/496118
[patent_app_country] => US
[patent_app_date] => 1995-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7750
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/830/05830854.pdf
[firstpage_image] =>[orig_patent_app_number] => 496118
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/496118 | Method of treating cystic fibrosis using a tachykinin receptor antagonist | Jun 26, 1995 | Issued |
Array
(
[id] => 3876550
[patent_doc_number] => 05747454
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-05
[patent_title] => 'Chromogranin peptides'
[patent_app_type] => 1
[patent_app_number] => 8/491544
[patent_app_country] => US
[patent_app_date] => 1995-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5866
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/747/05747454.pdf
[firstpage_image] =>[orig_patent_app_number] => 491544
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/491544 | Chromogranin peptides | Jun 15, 1995 | Issued |
Array
(
[id] => 3885794
[patent_doc_number] => 05776899
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-07
[patent_title] => 'Polypeptide and anti-HIV agent prepared therefrom'
[patent_app_type] => 1
[patent_app_number] => 8/454235
[patent_app_country] => US
[patent_app_date] => 1995-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8608
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 265
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/776/05776899.pdf
[firstpage_image] =>[orig_patent_app_number] => 454235
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/454235 | Polypeptide and anti-HIV agent prepared therefrom | Jun 12, 1995 | Issued |
Array
(
[id] => 3748101
[patent_doc_number] => 05717062
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-02-10
[patent_title] => 'Cyclic analogs of PTH and PTHrP'
[patent_app_type] => 1
[patent_app_number] => 8/488105
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6434
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 495
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/717/05717062.pdf
[firstpage_image] =>[orig_patent_app_number] => 488105
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/488105 | Cyclic analogs of PTH and PTHrP | Jun 6, 1995 | Issued |